Structured evidence table for Magnesium Sleep Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Magnesium Sleep Randomized Trial | 1 2 3 4 4 5 6 Postmenopausal osteoporosis is characterized by a diminished bone mineral density, bone microarchitecture changes and an increased fracture risk. | 2 | Pickering Marie-Eva (2026) | Quantitative sensory testing of pain in osteoporosis: a pilot randomized clinical trial with magnesium supplementation |
| Magnesium Sleep Randomized Trial | BPs may alleviate pain by several mechanisms: action on bone sensory pain fibers and ion channels, peripheral pain sensitization, increased transcription, central sensitization, nerve sprouting and epigenetic modulation []. | 2 | Pickering Marie-Eva (2026) | Quantitative sensory testing of pain in osteoporosis: a pilot randomized clinical trial with magnesium supplementation |
| Magnesium Sleep Randomized Trial | More specifically, with zoledronate, after 1 and 2 years of treatment, pain at rest and during standing were improved compared with placebo, especially in patients who sustained incident clinical fractures during the study []. | 2 | Pickering Marie-Eva (2026) | Quantitative sensory testing of pain in osteoporosis: a pilot randomized clinical trial with magnesium supplementation |
| Magnesium Sleep Randomized Trial | Osteoporosis is often silent and manifests itself especially when a fragility fracture occurs. | 2 | Pickering Marie-Eva (2026) | Quantitative sensory testing of pain in osteoporosis: a pilot randomized clinical trial with magnesium supplementation |
Source documents